Table 3.
Effect of NXY-059 on infarct volume by brain regional, stroke model, animal species, time from occlusion to treatment onset, length of treatment, loading dose and maintenance dose
| Group | Studies | Experiments | Animals | SMD | 95% CI | P-value | Heterogeneity P-value |
|---|---|---|---|---|---|---|---|
| Total volume | 15 | 26 | 585 | −1.17 | −1.50 to −0.84 | <0.0001 | <0.0001 |
| Cortical | 5 | 6 | 145 | −2.17 | −2.99 to −1.34 | <0.0001 | <0.0001 |
| Subcortical | 5 | 6 | 145 | −1.43 | −2.00 to −0.86 | <0.0001 | 0.05 |
| Species | |||||||
| Mice | 1 | 1 | 9 | −0.91 | −2.31 to 0.49 | 0.20 | – |
| Rats | 12 | 23 | 544 | −1.05 | −1.53 to −0.57 | <0.0001 | <0.0001 |
| Marmosets | 2 | 2 | 32 | −0.95 | −1.70 to −0.21 | 0.01 | 0.45 |
| Model | |||||||
| Permanent | 8 | 13 | 302 | −1.05 | −1.53 to −0.57 | <0.0001 | <0.0001 |
| Transient | 6 | 12 | 259 | −1.33 | 1.84 to −0.82 | <0.0001 | <0.0001 |
| Thrombotic | 1 | 1 | 24 | −1.08 | −2.00 to −0.16 | 0.02 | 0.47 |
| Start time (min) | |||||||
| −30 | 9 | 18 | 282 | −0.87 | −1.36 to −0.38 | 0.001 | <0.0001 |
| >30 to −60 | 1 | 1 | 10 | −2.36 | −4.29 to −0.43 | 0.02 | – |
| >60 to −120 | 1 | 2 | 34 | −1.21 | −2.03 to −0.40 | 0.003 | 0.63 |
| >120 to −180 | 4 | 9 | 208 | −1.47 | −2.04 to −0.89 | <0.0001 | 0.001 |
| 240 | 2 | 2 | 30 | −2.31 | −5.79 to 1.18 | 0.19 | 0.02 |
| 300 | 1 | 1 | 10 | −1.53 | −3.27 to 0.19 | 0.08 | – |
| 480 | 1 | 1 | 11 | −0.91 | −2.30 to 0.48 | 0.20 | – |
| Treatment length (h) | |||||||
| 0† | 2 | 3 | 39 | −2.19 | −4.21 to −0.16 | 0.03 | 0.006 |
| >0 to −24 | 10 | 19 | 489 | −1.08 | −1.44 to −0.71 | <0.0001 | <0.0001 |
| 48 | 3 | 3 | 47 | −1.13 | −1.76 to −0.50 | <0.0001 | 0.50 |
| 72 | 1 | 1 | 10 | −1.94 | −3.51 to −0.38 | 0.02 | – |
| Loading dose (mg·kg−1) | |||||||
| No load | 1 | 3 | 77 | −0.60 | −1.07 to −0.12 | 0.01 | 0.66 |
| ≤30 | 9 | 18 | 231 | −1.69 | −2.18 to −1.20 | <0.0001 | 0.004 |
| >30 to ≤60 | 3 | 12 | 154 | −0.88 | −1.58 to −0.18 | 0.01 | <0.0001 |
| >60 to ≤120 | 5 | 5 | 111 | −0.74 | −1.44 to −0.04 | 0.04 | 0.03 |
| 200 | 1 | 1 | 12 | −0.77 | −2.02 to 0.48 | 0.23 | – |
| Maintenance dose (mg·kg−1) | |||||||
| No maintenance | 2 | 3 | 39 | −2.19 | −4.21 to −0.16 | 0.03 | 0.01 |
| ≤30 | 9 | 20 | 326 | −1.23 | −1.63 to −0.82 | <0.0001 | 0.001 |
| >30 to ≤60 | 4 | 12 | 164 | −0.94 | −1.60 to −0.28 | 0.01 | <0.0001 |
| >60 to ≤120 | 3 | 3 | 44 | −1.07 | −2.69 to 0.56 | 0.20 | 0.01 |
| 200 | 1 | 1 | 12 | −0.77 | −2.02 to 0.48 | 0.23 | – |
Data are standardized mean difference (SMD), 95% confidence intervals (95% CI) and significance for effect and heterogeneity. Results in bold are statistically significant.
Two studies administered one or two loading doses only, without maintenance.
NXY-059, disodium 2,4-disulphophenyl-N-tert-butylnitrone.